PT-141, 10 mg

PT‑141 (Bremelanotide) is a synthetic melanocortin‑based peptide studied for its effects on neural pathways related to sexual arousal and motivation. Unlike compounds that act on vascular mechanisms, PT‑141 is investigated for its ability to influence central melanocortin receptors, particularly MC4R, which play roles in motivation, reward, and autonomic arousal. Research interest spans both male and female sexual‑function models, with studies examining how neural signaling, stress responses, and receptor activity contribute to arousal patterns.

Key Research Areas

• Central melanocortin activation — PT‑141 is studied for its ability to stimulate MC4R pathways involved in sexual desire, motivation, and reward‑related signaling.
• Arousal‑mechanism modeling — Research explores how PT‑141 may influence neural circuits rather than vascular responses, offering a distinct model for studying sexual‑arousal physiology.
• Neuroendocrine interactions — Investigations highlight its role in broader neuroendocrine processes, including appetite, energy balance, and stress‑response pathways.
• Applications across sexes — Studies examine PT‑141’s effects in both male and female models, focusing on desire, arousal, and behavioral responses.

⚠️ For Research Use Only
This product is not for human or veterinary use. It is intended strictly for laboratory research. Any mention of effects is based on scientific literature and does not imply approval by Health Canada or any regulatory agency